Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

796

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
AtherosclerosisHeterozygous Familial Hypercholesterolemia
Interventions
DRUG

Pactimibe sulfate

Trial Locations (37)

Unknown

Santa Ana

Chicago

Baltimore

St Louis

Cincinnati

Houston

Salt Lake City

Seattle

Vancouver

Toronto

Chicoutimi

Chomedey Laval

Montreal

Ste-Foy

Jerusalem

Amsterdam

Capelle aan den IJssel

Dordrecht

Etten-Leur

Goes

Gorinchem

Gouda

Groningen

Hoorn

Leiden

Rotterdam

Tilburg

Oslo

Bellville

Midrand

Pretoria

Barcelona

Córdoba

Linköping

Stockholm

London

Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY